Bipolar II Disorder
Modelling, Measuring and Managing

Now in its third edition, this book is the only academic and clinical management review focusing on bipolar II disorder.

Gordon Parker (Edited by)

9781108414111, Cambridge University Press

Paperback / softback, published 3 January 2019

318 pages
23.4 x 15.6 x 1.6 cm, 0.56 kg

The lifetime risk of developing bipolar II disorder is 5-7%, yet the condition is often poorly detected. Mood elevation states are less extreme than in bipolar I disorder although the depressive episodes are usually severe. When correctly treated, the outcome is positive, but bipolar II is often poorly managed, resulting in a high suicide rate. This is the only academic and clinical management review focused entirely on bipolar II, scrutinizing history, epidemiology, burden and neurobiology and including an extensive clinical debate by international experts about effective management strategies. Now in its third edition, this book features new chapters on the limitations to clinical treatment trials and perinatal management nuances. In a completely new section, international experts offer their personal responses and distinctive wisdom to key management issues and allow the reader to observe a variety of opinions.

Part I. Domain Chapters: 1. Mapping the terrain of bipolar II disorder Gordon Parker
2. Bipolar disorder in historical perspective Edward Shorter
3. The bipolar spectrum Chris B. Aiken
4. Defining and measuring bipolar II disorder as a categorical condition Gordon Parker
5. Bipolar II disorder in context: a review of its epidemiology, disability and economic burden Trisha Chakrabarty, George Hadjipavlou, David J. Bond and Lakshmi N. Yatham
6. Comorbid conditions associated with bipolar II disorder Gordon Parker and Stacey McCraw
7. Personality and temperament styles associated with bipolar II disorder Tahlia Ricciardi
8. Differentiating bipolar II disorder from personality-based dysregulation disorders Joel Paris and Adam Bayes
9. The neurobiology of bipolar II disorder Emre Bora and Christos Pantelis
10. Methodological nuances in undertaking and interpreting efficacy studies of medications for bipolar II disorder Gabriela Tavella and Gordon Parker
11. The role of antidepressants in managing bipolar II disorder Joseph F. Goldberg
12. Mood stabilizers in the treatment of bipolar II disorder David J. Bond, George Hadjipavlou and Lakshmi N. Yatham
13. The use of antipsychotic drugs in bipolar II disorder Eduard Vieta
14. Perinatal nuances in managing bipolar II disorder Gabriela Tavella and Philip Boyce
15. Psychological interventions for managing bipolar II disorder Vijaya Manicavasagar and David Gilfillan
16. The role of wellbeing plans in managing bipolar II disorder Margo Orum
17. The trajectory of illness experienced by those with a bipolar II disorder Tessa Cleradin
Part II. Management Commentaries: 18. Introduction to management commentaries Gordon Parker
19. Management commentary Jay Amsterdam and Lorenzo Lorenzo-Luaces
20. Management commentary Darryl Bassett
21. Management commentary David Castle
22. Management commentary Kostantinos N. Fountoulakis
23. Management commentary Sophia Frangou
24. Management commentary Heinz Grunze
25. Management commentary Tadafumi Kato
26. Management commentary Gin Malhi
27. Management commentary Philip B. Mitchell
28. Management commentary Lawrence T. Park and Carlos A. Zarate, Jr
29. Management commentary Robert Post
30. Management commentary Joshua Rosenblat and Roger McIntyre
31. Management commentary Ayal Schaffer
32. Management commentary Michael E. Thase
33. Management commentary Mauricio Tohen
34. Management commentary Eduard Vieta
35. Management commentary Lakshmi Yatham
36. Management commentary Allan Young
Part III. Conclusion: 37. Rounding up Gordon Parker.

Subject Areas: Clinical psychology [MMJ], Psychiatry [MMH], Pharmacology [MMG]